Sight Sciences, Inc. SGHT Business Segments
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Revenue by Business | ||||||
| Dry Eye | $1.35M+244% | $724K+138% | $188K-87.7% | $333K-70.4% | $394K-60.9% | |
| Surgical Glaucoma | $18.34M+7.2% | $19.66M+4.7% | $19.72M+5.8% | $19.23M-5.0% | $17.11M-6.3% | |
| Gross Profit by Business | ||||||
| Dry Eye | $976K+251% | $495K+219% | $71K-90.2% | $128K-75.6% | $278K-34.4% | |
| Surgical Glaucoma | $16M+8.0% | $17.29M+5.4% | $17.13M+5.9% | $16.46M-7.6% | $14.82M-7.7% | |
| Cost of Goods Sold by Business | ||||||
| Dry Eye | $378K+226% | $229K+53.7% | $117K-85.3% | $205K-65.9% | $116K-80.1% | |
| Surgical Glaucoma | $2.34M+1.9% | $2.37M+0.2% | $2.59M+5.7% | $2.77M+14.4% | $2.3M+4.0% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Sight Sciences, Inc. break its business down?
- Sight Sciences, Inc. (SGHT) reports revenue by business across 2 parts — Dry Eye and Surgical Glaucoma. Each is extracted from the segment footnotes and tracked over time.
- Where does Sight Sciences, Inc.'s segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Sight Sciences, Inc.'s SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
